Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ HSD17B3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA530063
Description
Recommended positive controls: Raji. Predicted reactivity: Pig (81%), Rhesus Monkey (97%), Bovine (82%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone. It preferentially uses NADP as cofactor. Deficiency can result in male pseudohermaphroditism with gynecomastia.
Specifications
HSD17B3 | |
Polyclonal | |
Unconjugated | |
HSD17B3 | |
17(beta)HSD type 3; 17beta-HSD; 17-beta-HSD 3; 17-beta-HSD3; 17-beta-hydroxysteroid dehydrogenase type 3; Edh17b3; estradiol 17 beta-dehydrogenase 3; HSD17B3; hydroxysteroid (17-beta) dehydrogenase 3; hydroxysteroid 17-beta dehydrogenase 3; hydroxysteroid dehydrogenase 3; SDR12C2; Short chain dehydrogenase/reductase family 12C member 2; short chain dehydrogenase/reductase family 12C, member 2; testicular 17-beta-hydroxysteroid dehydrogenase; Testosterone 17-beta-dehydrogenase 3 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
117182, 15487, 3293 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.44 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.025% ProClin 300; pH 7 | |
O54939, P37058, P70385 | |
HSD17B3 | |
Recombinant fragment corresponding to a region within amino acids 122 and 310 of Human HSD17B3. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction